This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe
Save the Date: 2-4 December 2024
Convention Centre DublinDublin, Ireland

Ketki Vispute
Associate Director, CAR-T Manufacturing at Autolus
Speaker

Profile

I have 10+ years experience in developement and manufacturing of CAR-T cells for haematological malignancies. my team was the first in Europe to launch the first ever CAR-T cell trial from designing the CAR construct through to pre-clinical developement followed by scaling up of the process to manufacturing for clinical trials. I have delivered 4 phase 1/2 clinical trials and further taken one trial through phase 3. We are now launching our first commercial CAR-T product manufactured in the UK, imminently.

Agenda Sessions

  • CAR-T Manufacturing - Process Development to Clinical Trials through to Commercialisation

    09:00